Tag-Archive for ◊ DePuy Orthopaedics ◊

• Thursday, November 21st, 2013

A unit of Johnson & Johnson has agreed to pay an estimated $2.5 billion to settle thousands of lawsuits from individuals allegedly injured by the company’s artificial hip implants, the company announced Tuesday. The settlement, announced during a hearing in federal court in Ohio on Tuesday, would compensate an estimated 8,000 patients who underwent surgery […]

• Friday, August 16th, 2013

Codman & Shurtleff, a division of Johnson & Johnson subsidiary DePuy Synthes, gets the FDA’s highest warning level for issues with certain lots of its programmable infusion pumps. The FDA puts its highest-risk label on a recall of programmable infusion pumps made by Codman & Shurtleff Inc., a division of Johnson & Johnson (NYSE:JNJ) subsidiary […]

• Wednesday, July 24th, 2013

DePuy Synthes sues a pair of former sales representatives after they jump ship for Sky Surgical, a distributor for rival Globus Medical. Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes Sales filed a breach of contract lawsuit against a pair of former sales reps who jumped ship for Sky Surgical, a distributor for rival medical device company Globus […]

• Thursday, July 04th, 2013

Johnson & Johnson subsidiary DePuy asks an Ohio judge to bar the testimony of pair of expert witnesses who testified against DePuy in a patient injury lawsuit earlier this year. Attorneys for Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics moved this week to prevent a couple of expert witnesses from testifying during a metal-on-metal hip implant lawsuit […]

• Friday, June 07th, 2013

The world’s largest healthcare group Johnson & Johnson (J & J) is struggling with the integration of almost a year ago for $ 19.7 billion acquired Swiss-American orthopedic specialist Synthes. “We still have less than half of the necessary work done,” says Michel Orsinger, head of the newly created business unit DePuy Synthes, frankly. In […]

• Thursday, May 30th, 2013

Johnson & Johnson and its DePuy Orthopaedics subsidiary lose a bid to dismiss a $8.3 million loss in a patient injury lawsuit over the company’s recalled metal-on-metal hip implants. Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics is still responsible for an $8.3 million award to a patient who claimed the companies were responsible for injuries caused by […]

• Wednesday, May 29th, 2013

The orthopedic unit of Johnson & Johnson said Thursday that it was phasing out production of all-metal replacement hips, a move reflecting an industrywide trend to abandon the once widely used implants because of high early failure rates. In 2010, the company, DePuy Orthopaedics, recalled an all-metal model known as the Articular Surface Replacement, or A.S.R., because […]